These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2284099)

  • 1. Overexpression of transfected cathepsin D in transformed cells increases their malignant phenotype and metastatic potency.
    Garcia M; Derocq D; Pujol P; Rochefort H
    Oncogene; 1990 Dec; 5(12):1809-14. PubMed ID: 2284099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cells.
    Glondu M; Liaudet-Coopman E; Derocq D; Platet N; Rochefort H; Garcia M
    Oncogene; 2002 Aug; 21(33):5127-34. PubMed ID: 12140763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfected cathepsin D stimulates high density cancer cell growth by inactivating secreted growth inhibitors.
    Liaudet E; Derocq D; Rochefort H; Garcia M
    Cell Growth Differ; 1995 Sep; 6(9):1045-52. PubMed ID: 8519680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin D maturation and its stimulatory effect on metastasis are prevented by addition of KDEL retention signal.
    Liaudet E; Garcia M; Rochefort H
    Oncogene; 1994 Apr; 9(4):1145-54. PubMed ID: 8134116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of the overexpression of the cathepsin D gene in breast cancer and consequences in the metastatic process].
    Rochefort H
    C R Seances Soc Biol Fil; 1991; 185(6):415-21. PubMed ID: 1822391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of metastatic ability in a stably diploid benign rat mammary epithelial cell line by transfection with DNA from human malignant breast carcinoma cell lines.
    Davies BR; Barraclough R; Rudland PS
    Cancer Res; 1994 May; 54(10):2785-93. PubMed ID: 8168111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.
    Glondu M; Coopman P; Laurent-Matha V; Garcia M; Rochefort H; Liaudet-Coopman E
    Oncogene; 2001 Oct; 20(47):6920-9. PubMed ID: 11687971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M; Yao J; Yu D
    Cancer Res; 1997 Mar; 57(6):1199-205. PubMed ID: 9067293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
    Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D in breast cancer: from molecular and cellular biology to clinical applications.
    Rochefort H; Capony F; Garcia M
    Cancer Cells; 1990 Dec; 2(12):383-8. PubMed ID: 1965134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy.
    Vashishta A; Ohri SS; Proctor M; Fusek M; Vetvicka V
    Int J Oncol; 2007 May; 30(5):1223-30. PubMed ID: 17390025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological and clinical significance of cathepsin D in breast cancer metastasis.
    Garcia M; Platet N; Liaudet E; Laurent V; Derocq D; Brouillet JP; Rochefort H
    Stem Cells; 1996 Nov; 14(6):642-50. PubMed ID: 8948022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.
    Gallegos A; Gasdaska JR; Taylor CW; Paine-Murrieta GD; Goodman D; Gasdaska PY; Berggren M; Briehl MM; Powis G
    Cancer Res; 1996 Dec; 56(24):5765-70. PubMed ID: 8971189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells.
    Miyake H; Hara I; Yamanaka K; Gohji K; Arakawa S; Kamidono S
    Br J Cancer; 1999 Apr; 79(11-12):1651-6. PubMed ID: 10206273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.
    Yu D; Shi D; Scanlon M; Hung MC
    Cancer Res; 1993 Dec; 53(23):5784-90. PubMed ID: 7902209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of glycosphingolipids in the expression of neoplastic phenotype. III. Changes in glycosphingolipids related to the capacity of neoplastic cells for metastasis and tumor growth in vivo].
    Ugorski M
    Postepy Hig Med Dosw; 1992; 46(2):191-208. PubMed ID: 1470581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of protein kinase C epsilon is oncogenic in rat colonic epithelial cells.
    Perletti GP; Folini M; Lin HC; Mischak H; Piccinini F; Tashjian AH
    Oncogene; 1996 Feb; 12(4):847-54. PubMed ID: 8632907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
    Choe C; Chen N; Sawadogo M
    Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.